Representative Carol D. Miller (R-West Virginia) recently bought shares of Aflac Incorporated (NYSE:AFL). In a filing disclosed on April 11th, the Representative disclosed that they had bought between $1,001 and $15,000 in Aflac stock on March 10th. The trade occurred in the Representative’s “MATT MILLER INVESTMENT MANAGEMENT ACCOUNT” account.
Representative Carol D. Miller also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 3/10/2025.
- Purchased $1,001 – $15,000 in shares of Gilead Sciences (NASDAQ:GILD) on 3/10/2025.
- Sold $1,001 – $15,000 in shares of Pfizer (NYSE:PFE) on 3/10/2025.
- Purchased $1,001 – $15,000 in shares of Lockheed Martin (NYSE:LMT) on 3/10/2025.
- Purchased $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 3/10/2025.
- Purchased $1,001 – $15,000 in shares of Honeywell International (NASDAQ:HON) on 3/10/2025.
- Sold $1,001 – $15,000 in shares of U.S. Bancorp (NYSE:USB) on 3/10/2025.
- Purchased $1,001 – $15,000 in shares of CME Group (NASDAQ:CME) on 3/10/2025.
- Sold $1,001 – $15,000 in shares of Target (NYSE:TGT) on 3/10/2025.
- Purchased $1,001 – $15,000 in shares of American Water Works (NYSE:AWK) on 3/10/2025.
Aflac Price Performance
Shares of Aflac stock opened at $108.02 on Wednesday. Aflac Incorporated has a 52 week low of $79.69 and a 52 week high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The stock has a market cap of $58.96 billion, a PE ratio of 11.25, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The company’s 50-day moving average price is $106.46 and its two-hundred day moving average price is $107.40.
Insider Activity at Aflac
In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Charles D. Lake II sold 29,802 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the transaction, the director now owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Aflac
Several institutional investors have recently bought and sold shares of the stock. Whipplewood Advisors LLC bought a new position in shares of Aflac in the 4th quarter valued at approximately $26,000. BankPlus Trust Department acquired a new position in Aflac during the fourth quarter valued at approximately $34,000. Curio Wealth LLC bought a new position in shares of Aflac in the fourth quarter valued at approximately $36,000. OFI Invest Asset Management acquired a new stake in shares of Aflac in the fourth quarter worth $38,000. Finally, Capital A Wealth Management LLC bought a new stake in shares of Aflac during the 4th quarter worth $38,000. 67.44% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
AFL has been the topic of a number of analyst reports. Barclays dropped their price target on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Morgan Stanley cut their target price on shares of Aflac from $105.00 to $100.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 10th. Piper Sandler lifted their price target on Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a report on Wednesday, April 2nd. Finally, Wells Fargo & Company reduced their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Aflac has an average rating of “Hold” and an average target price of $103.93.
Check Out Our Latest Stock Report on Aflac
About Representative Miller
Carol Miller (Republican Party) is a member of the U.S. House, representing West Virginia’s 1st Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
Miller (Republican Party) ran for re-election to the U.S. House to represent West Virginia’s 1st Congressional District. She won in the general election on November 5, 2024.
West Virginia’s 3rd Congressional District race was identified as a 2018 battleground that might have affected partisan control of the U.S. House in the 116th Congress. Incumbent Evan Jenkins (R) did not seek re-election in 2018, leaving the seat open. In the campaign, Miller emphasized her endorsement by President Donald Trump (R). Lara Trump, Senior Advisor to Donald J. Trump for President, Inc., said, “Carol is pro-coal, pro-Second Amendment, and pro-Trump through and through, and is prepared to tackle the opioid epidemic that’s affected countless West Virginians.” Miller also supported the construction of a wall on the southern U.S. border and the Tax Cuts and Jobs Act (TCJA).
Miller is a former Republican member of the West Virginia House of Delegates, representing District 16 from 2006 to 2018.
Miller has also worked in real estate and owns a bison farm.
Carol Miller was born in Columbus, Ohio. Miller graduated from Bexley High School in 1968. She earned a B.S. from Columbia College in 1972. Her career experience includes owning and operating Swann Ridge Bison Farm and working as a real estate manager.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Recommended Stories
- Five stocks we like better than Aflac
- What Are Growth Stocks and Investing in Them
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- How to Calculate Options Profits
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- What is Put Option Volume?
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.